<DOC>
	<DOC>NCT01175889</DOC>
	<brief_summary>The Megadyne Aceâ„¢ Incision/ Dissection study is a post market, prospective assessment of the E-Z Clean ACE electrosurgical electrodes using the ACE Blade in the ACE Mode for targeted procedures such as abdominoplasty, bilateral breast reduction, bilateral breast lifts, bilateral brachioplasty, bilateral lateral thigh and buttocks lifts, or any combination thereof.</brief_summary>
	<brief_title>Megadyne Ace Incision/Dissection Study</brief_title>
	<detailed_description />
	<criteria>Subject is &gt;18 years of age or &lt; 60 years old Subject is undergoing abdominoplasty, bilateral breast reduction, bilateral breast lift, bilateral brachioplasty, bilateral lateral thigh and buttocks lift, or any combination thereof Subject is able to discontinue anticoagulant therapy (including Aspirin) Subject is willing and able to comply with study followup procedures Subject is willing to provide written informed consent for their participation in the study Subject has a history of smoking in the last 6 months prior to surgery. Subject has a history of type I or type II Diabetes. Subject has an active infection of any kind at the time of enrollment Subject has a known coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>